State MT
Clinical Trials in Montana
Recruiting clinical trials with at least one study location in Montana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Montana
Stage IVB Prostate Cancer AJCC v8 (4)Chronic Lymphocytic Leukemia (3)Castration-Resistant Prostate Carcinoma (3)Non-small Cell Lung Cancer (2)Small Lymphocytic Lymphoma (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Breast Cancer (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Acute Myeloid Leukemia (2)Chronic Condition (1)Chronic Pain (1)
Frequently Asked Questions — Clinical Trials in Montana
How many clinical trials are currently recruiting in Montana?
ClinicalMetric currently tracks 36 actively recruiting clinical trials with at least one location in Montana. The total number of registered studies—including active but not currently enrolling trials—is 36. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Montana?
Montana hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Chronic Lymphocytic Leukemia, Castration-Resistant Prostate Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Montana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Montana?
To join a clinical trial in Montana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Montana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Montana
NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06070766 N/A
Recruiting
RIVER At Home Ketamine Protocols
Condition
Chronic Condition
Enrollment
50,000 pts
Location
United States
Sponsor
RIVER Foundation
NCT06162221 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition
Non-Small Cell Lung Cancer, NSCLC
Enrollment
616 pts
Location
United States, Australia, Denmark
Sponsor
Revolution Medicines, Inc.
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06546020 N/A
Recruiting
Gut Microbiota-dependent Health Impacts of Haskap Berries
Condition
Metabolic Disease
Enrollment
120 pts
Location
United States
Sponsor
Montana State University
NCT07556159 N/A
Recruiting
A Study Evaluating Disease Characteristics and Outcomes in Participants With Ast...
Condition
Asthma
Enrollment
2,500 pts
Location
United States
Sponsor
Sanofi
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT06649812 Phase 2
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients...
Condition
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
Enrollment
120 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06496620 Phase 2
Recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Condition
COPD
Enrollment
171 pts
Location
United States, Australia, Canada
Sponsor
Uniquity One (UNI)
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT04489719 N/A
Recruiting
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Me...
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
48 pts
Location
United States
Sponsor
University of Washington
NCT06760637 Phase 3
Recruiting
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Bre...
Condition
Breast Cancer
Enrollment
1,020 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06345729 Phase 3
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants Wit...
Condition
Non-small Cell Lung Cancer
Enrollment
600 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06136559 Phase 3
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of I...
Condition
Chronic Lymphocytic Leukemia
Enrollment
1,200 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06777368 N/A
Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failu...
Condition
Aortic Stenosis
Enrollment
225 pts
Location
United States
Sponsor
Medtronic Cardiovascular
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT06504446 Phase 2
Recruiting
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With...
Condition
Refractory or Unexplained Chronic Cough
Enrollment
455 pts
Location
United States, Belgium, Canada
Sponsor
Nocion Therapeutics
Page 1 of 2 — 36 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology